Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
UNQ Holdings Limited ( (HK:2177) ) has issued an announcement.
UNQ Holdings Limited has renewed its Products Procurement Framework Agreement with TCI, effective from January 1, 2026, to December 31, 2028. This agreement involves the purchase and sale of products manufactured by Japanese brand partners, which are significant for the company’s operations. The renewal constitutes continuing connected transactions under the Listing Rules, requiring annual reporting and independent shareholder approval. An Independent Board Committee and DL Securities have been appointed to advise on the agreement, and a circular with transaction details will be dispatched to shareholders by November 28, 2025.
The most recent analyst rating on (HK:2177) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on UNQ Holdings Limited stock, see the HK:2177 Stock Forecast page.
More about UNQ Holdings Limited
UNQ Holdings Limited is a company incorporated in the Cayman Islands, operating in the procurement and distribution industry. It focuses on acquiring and selling products, including OTC drugs and healthcare products from Japanese brands such as Nichiban, Ohta’s Isan, Taisho, Santen, Daiichi Sankyo, LOXONIN, Senju, and Zeria.
Average Trading Volume: 78,380
Technical Sentiment Signal: Buy
Current Market Cap: HK$467.8M
Find detailed analytics on 2177 stock on TipRanks’ Stock Analysis page.